Acs Medicinal Chemistry Letters

SCIE

國際簡稱：ACS Med. Chem. Lett. 參考譯名：Acs 藥物化學(xué)快報(bào)

主要研究方向：CHEMISTRY, MEDICINAL 非預(yù)警期刊審稿周期：一般,3-8周

《Acs 藥物化學(xué)快報(bào)》(Acs Medicinal Chemistry Letters)是一本由American Chemical Society出版的以CHEMISTRY, MEDICINAL為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
216 年發(fā)文量
3.5 IF影響因子
開放是否OA
52 H-index
2010 創(chuàng)刊年份
Monthly 出版周期
English 出版語言

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to:

Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics)

Biological characterization of new molecular entities in the context of drug discovery

Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands and their targets, etc.

Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry

Discovery technologies for biologically active molecules from both synthetic and natural (plant and other) sources

Pharmacokinetic/pharmacodynamic studies that address mechanisms underlying drug disposition and response

Pharmacogenetic and pharmacogenomic studies used to enhance drug design and the translation of medicinal chemistry into the clinic

Mechanistic drug metabolism and regulation of metabolic enzyme gene expression

Chemistry patents relevant to the medicinal chemistry field.

[ 查看全部 ]

投稿咨詢加急咨詢

Acs Medicinal Chemistry Letters期刊信息

ISSN：1948-5875
出版語言：English
是否OA：開放
出版地區(qū)：UNITED STATES
是否預(yù)警：否
出版商：American Chemical Society
出版周期：Monthly
創(chuàng)刊時(shí)間：2010
開源占比：0.1324
Gold OA文章占比：16.64%
OA被引用占比：0.0295...
出版國人文章占比：0.09
出版撤稿占比：0
研究類文章占比：100.00%

Acs Medicinal Chemistry Letters CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

7.3

0.883

0.816

學(xué)科類別	分區(qū)	排名	百分位
大類：Chemistry 小類：Organic Chemistry	Q1	43 / 211	79%
大類：Chemistry 小類：Drug Discovery	Q2	45 / 157	71%
大類：Chemistry 小類：Biochemistry	Q2	134 / 438	69%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Acs Medicinal Chemistry Letters中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué)	3區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué)	3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué)	2區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué)	3區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué)	2區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	CHEMISTRY, MEDICINAL 藥物化學(xué)	2區(qū)

Acs Medicinal Chemistry Letters JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CHEMISTRY, MEDICINAL	SCIE	Q2	32 / 72	56.3%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CHEMISTRY, MEDICINAL	SCIE	Q2	21 / 72	71.53%

Acs Medicinal Chemistry Letters歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Acs Medicinal Chemistry Letters中國學(xué)者發(fā)文選摘

1、Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue
Author: Song, Jun; Pan, Chuqiao; Li, Jinxiu; Bai, Ruisong; Zeng, Ziying; Han, Yunying; Chen, Zhao; Hou, Wei; Li, Yong; Ruan, Benfang Helen

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. 14, Issue 1, pp. 11-17. DOI: 10.1021/acsmedchemlett.2c00302
2、Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors
Author: Liu, Meiying; Zhou, Guizhen; Su, Wenhong; Gu, Yuejiao; Gao, Mingshan; Wang, Kun; Huo, Ruifeng; Li, Yupeng; Zhou, Zehui; Chen, Kaixian; Zheng, Mingyue; Zhang, Sulin; Xu, Tianfeng

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00490
3、Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors
Author: Liu, Meiying; Zhou, Guizhen; Su, Wenhong; Gu, Yuejiao; Gao, Mingshan; Wang, Kun; Huo, Ruifeng; Li, Yupeng; Zhou, Zehui; Chen, Kaixian; Zheng, Mingyue; Zhang, Sulin; Xu, Tianfeng

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. 183-190. DOI: 10.1021/acsmedchemlett.2c00490183
4、Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design
Author: Yu, Yang; Huang, Junhong; He, Hu; Han, Jing; Ye, Geyan; Xu, Tingyang; Sun, Xianqiang; Chen, Xiumei; Ren, Xiaoming; Li, Chunlai; Li, Huijuan; Huang, Wei; Liu, Yangyang; Wang, Xinjuan; Gao, Yongzhi; Cheng, Nianhe; Guo, Na; Chen, Xibo; Feng, Jianxia; Hua, Yuxia; Liu, Chong; Zhu, Guoyun; Xie, Zhi; Yao, Lili; Zhong, Wenge; Chen, Xinde; Liu, Wei; Li, Hailong

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00515
5、Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong In Vivo Anticancer Activity
Author: Hou, Wei; Chen, Zhao; Pan, Chuqiao; Ni, Maowei; Ruan, Haoqiang; Song, Jun; Lu, Shiying; Bhasin, Aman; Ruan, Benfang Helen

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00470
6、Development and Characterization of Fluorescent Probes for the G Protein-Coupled Receptor 35
Author: Wei, Lai; Xiang, Kaijing; Kang, Hongjian; Yu, Yancheng; Fan, Hongjie; Zhou, Han; Hou, Tao; Ge, Yonglin; Wang, Jixia; Guo, Zhimou; Chen, Yang; Zhao, Yaopeng; Liang, Xinmiao

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00461
7、Development of the Inverse Sonogashira Reaction for DEL Synthesis
Author: Luo, Ayun; Zhou, Hongxia; Hua, Qini; An, Yufang; Ma, Hangke; Zhao, Xue; Yang, Kexin; Hu, Yun Jin

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00477
8、Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist
Author: Dickson, Louise; Teall, Martin; Chevalier, Elodie; Cheung, Toni; Liwicki, Gemma M.; Mack, Stephen; Stephenson, Anne; White, Kathryn; Fosbeary, Richard; Harrison, David C.; Brice, Nicola L.; Doyle, Kevin; Ciccocioppo, Roberto; Wu, Chaobo; Almond, Sarah; Patel, Toshal R.; Mitchell, Philip; Barnes, Matt; Ayscough, Andrew P.; Dawson, Lee A.; Carlton, Mark; Burli, Roland W.

Journal: ACS MEDICINAL CHEMISTRY LETTERS. 2023; Vol. , Issue , pp. -. DOI: 10.1021/acsmedchemlett.2c00529